{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:26:18Z","timestamp":1784647578525,"version":"3.55.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPD1K0352"],"award-info":[{"award-number":["CMRPD1K0352"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Inhaled nitric oxide (iNO) has a beneficial effect on hypoxemic respiratory failure. The increased use of concurrent iNO and milrinone was observed. We aimed to report the trends of iNO use in the past 15 years in Taiwan and compare the first-year outcomes of combining iNO and milrinone to the iNO alone in very low birth weight preterm (VLBWP) infants under mechanical ventilation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This nationwide cohort study enrolled preterm singleton infants with birth weight &lt;1500g treated with iNO from 2004 to 2019. Infants were divided into two groups, with a combination of intravenous milrinone (Group 2, n = 166) and without milrinone (Group 1, n = 591). After propensity score matching (PSM), each group\u2019s sample size is 124. The primary outcomes were all-cause mortality and the respiratory condition, including ventilator use and duration. The secondary outcomes were preterm morbidities within one year after birth.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>After PSM, more infants in Group 2 needed inotropes. The mortality rate was significantly higher in Group 2 than in Group 1 from one month after birth till 1 year of age (55.1% vs. 13.5%) with the adjusted hazard ratio of 4.25 (95%CI = 2.42\u20137.47, p &lt;0.001). For infants who died before 36 weeks of postmenstrual age (PMA), Group 2 had longer hospital stays compared to Group 1. For infants who survived after 36 weeks PMA, the incidence of moderate and severe bronchopulmonary dysplasia (BPD) was significantly higher in Group 2 than in Group 1. For infants who survived until one year of age, the incidence of pneumonia was significantly higher in Group 2 (28.30%) compared to Group 1 (12.62%) (p = 0.0153).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Combined treatment of iNO and milrinone is increasingly applied in VLBWP infants in Taiwan. This retrospective study did not support the benefits of combining iNO and milrinone on one-year survival and BPD prevention. A future prospective study is warranted.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0297137","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T17:31:16Z","timestamp":1715275876000},"page":"e0297137","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["First-year outcomes of very low birth weight preterm singleton infants with hypoxemic respiratory failure treated with milrinone and inhaled nitric oxide (iNO) compared to iNO alone: A nationwide retrospective study"],"prefix":"10.1371","volume":"19","author":[{"given":"Ya-Ting","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Rou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Nan","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-8969","authenticated-orcid":true,"given":"Lai-Chu","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"issue":"25","key":"pone.0297137.ref001","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1161\/01.CIR.0000134595.80170.62","article-title":"Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential","volume":"109","author":"F Ichinose","year":"2004","journal-title":"Circulation"},{"issue":"9","key":"pone.0297137.ref002","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199702273360901","article-title":"Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.","volume":"336","author":"Neonatal Inhaled Nitric Oxide Study G","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0297137.ref003","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/jp.2016.44","article-title":"Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates","volume":"36","author":"S Lakshminrusimha","year":"2016","journal-title":"J Perinatol"},{"issue":"4","key":"pone.0297137.ref004","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa060442","article-title":"Early inhaled nitric oxide therapy in premature newborns with respiratory failure","volume":"355","author":"JP Kinsella","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0297137.ref005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/pr.2017.200","article-title":"Controversies in the identification and management of acute pulmonary hypertension in preterm neonates","volume":"82","author":"RE Giesinger","year":"2017","journal-title":"Pediatr Res"},{"issue":"13","key":"pone.0297137.ref006","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1056\/NEJM198309293091302","article-title":"Evaluation of a new bipyridine inotropic agent\u2014milrinone\u2014in patients with severe congestive heart failure","volume":"309","author":"DS Baim","year":"1983","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0297137.ref007","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/PCC.0000000000000898","article-title":"Inotropic therapy in newborns, a population-based national registry study.","volume":"17","author":"ML Burns","year":"2016","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"pone.0297137.ref008","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00431-010-1296-2","article-title":"Use of milrinone in the management of haemodynamic instability following duct ligation","volume":"170","author":"A Sehgal","year":"2011","journal-title":"Eur J Pediatr"},{"issue":"4","key":"pone.0297137.ref009","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000444895","article-title":"Advances in neonatal pulmonary hypertension","volume":"109","author":"RH Steinhorn","year":"2016","journal-title":"Neonatology"},{"issue":"8","key":"pone.0297137.ref010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1055\/s-0036-1597996","article-title":"Milrinone pharmacokinetics and pharmacodynamics in neonates with persistent pulmonary hypertension of the newborn","volume":"34","author":"A Giaccone","year":"2017","journal-title":"Am J Perinatol"},{"issue":"1","key":"pone.0297137.ref011","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PCC.0b013e31824ea2cd","article-title":"Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide","volume":"14","author":"PJ McNamara","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"pone.0297137.ref012","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3108","article-title":"Inhaled nitric oxide in extremely premature neonates with respiratory distress syndrome","volume":"141","author":"WA Carey","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"pone.0297137.ref013","doi-asserted-by":"crossref","first-page":"e000897","DOI":"10.1136\/bmjpo-2020-000897","article-title":"Increase in the use of inhaled nitric oxide in neonatal intensive care units in England: a retrospective population study","volume":"5","author":"NV Subhedar","year":"2021","journal-title":"BMJ Paediatr Open"},{"issue":"38","key":"pone.0297137.ref014","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"M Humbert","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"pone.0297137.ref015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00003246-200003000-00031","article-title":"Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension","volume":"28","author":"B Deb","year":"2000","journal-title":"Crit Care Med"},{"issue":"2","key":"pone.0297137.ref016","first-page":"209","article-title":"Set-up and future applications of the Taiwan Maternal and Child Health Database (TMCHD).","volume":"35","author":"CY Li","year":"2016","journal-title":"Taiwan Journal of Public Health"},{"issue":"4","key":"pone.0297137.ref017","first-page":"297","article-title":"Validation of the Taiwan Birth Registry using obstetric records","volume":"103","author":"CM Lin","year":"2004","journal-title":"J Formos Med Assoc"},{"key":"pone.0297137.ref018","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan\u2019s National Health Insurance Research Database: past and future.","volume":"11","author":"CY Hsieh","year":"2019","journal-title":"Clin Epidemiol."},{"issue":"2","key":"pone.0297137.ref019","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ije\/29.2.336","article-title":"Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics.","volume":"29","author":"TH Lu","year":"2000","journal-title":"Int J Epidemiol"},{"key":"pone.0297137.ref020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jpeds.2018.01.043","article-title":"Bronchopulmonary dysplasia: executive summary of a workshop","volume":"197","author":"RD Higgins","year":"2018","journal-title":"J Pediatr"},{"issue":"4","key":"pone.0297137.ref021","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-3016.1997.d01-23.x","article-title":"Does gestational age in combination with birthweight provide better statistical adjustment of neonatal mortality rates than birthweight alone?","volume":"11","author":"M. Coory","year":"1997","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"3","key":"pone.0297137.ref022","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"PC Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"19","key":"pone.0297137.ref023","first-page":"3388","article-title":"A tutorial on propensity score estimation for multiple treatments using generalized boosted models.","volume":"32","author":"DF McCaffrey","year":"2013","journal-title":"Stat Med.PubMed Central PMCID"},{"issue":"3","key":"pone.0297137.ref024","doi-asserted-by":"crossref","first-page":"e18174","DOI":"10.1371\/journal.pone.0018174","article-title":"Weight trimming and propensity score weighting.","volume":"6","author":"BK Lee","year":"2011","journal-title":"PloS one."},{"issue":"6","key":"pone.0297137.ref025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"PC Austin","year":"2016","journal-title":"Circulation"},{"issue":"11","key":"pone.0297137.ref026","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/jp.2014.105","article-title":"Inhaled nitric oxide usage in preterm infants in the NICHD Neonatal Research Network: inter-site variation and propensity evaluation","volume":"34","author":"WE Truog","year":"2014","journal-title":"J Perinatol"},{"issue":"4","key":"pone.0297137.ref027","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/jp.2014.208","article-title":"Treatment of premature infants with pulmonary hypertension and right ventricular dysfunction with milrinone: a case series","volume":"35","author":"AT James","year":"2015","journal-title":"J Perinatol"},{"key":"pone.0297137.ref028","doi-asserted-by":"crossref","first-page":"105618","DOI":"10.1016\/j.earlhumdev.2022.105618","article-title":"Mortality after 36 weeks postmenstrual age of extremely preterm infants in neonatal care: the impact of growth impairment and bronchopulmonary dysplasia.","volume":"171","author":"T Dassios","year":"2022","journal-title":"Early Hum Dev."},{"issue":"2","key":"pone.0297137.ref029","doi-asserted-by":"crossref","first-page":"e2146404","DOI":"10.1001\/jamanetworkopen.2021.46404","article-title":"Deaths in a modern cohort of extremely preterm infants from the preterm erythropoietin neuroprotection trial","volume":"5","author":"SE Juul","year":"2022","journal-title":"JAMA Netw Open"},{"key":"pone.0297137.ref030","doi-asserted-by":"crossref","first-page":"105613","DOI":"10.1016\/j.earlhumdev.2022.105613","article-title":"The clinical burden of extremely preterm birth in a large medical records database in the United States: mortality and survival associated with selected complications.","volume":"171","author":"C Siffel","year":"2022","journal-title":"Early Hum Dev."},{"issue":"1","key":"pone.0297137.ref031","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1017\/S1047951114002698","article-title":"The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension","volume":"26","author":"AT James","year":"2016","journal-title":"Cardiol Young"},{"issue":"1","key":"pone.0297137.ref032","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000327891","article-title":"Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia","volume":"101","author":"DH Kim","year":"2012","journal-title":"Neonatology"},{"issue":"4","key":"pone.0297137.ref033","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-0028-1104743","article-title":"Inhaled nitric oxide for preterm premature rupture of membranes, oligohydramnios, and pulmonary hypoplasia.","volume":"26","author":"VY Chock","year":"2009","journal-title":"Am J Perinatol."},{"issue":"2","key":"pone.0297137.ref034","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/1570163814666171017162730","article-title":"Inhaled nitric oxide in preterm neonates with refractory hypoxemia associated to oligohydramnios","volume":"15","author":"JL Alvarado Socarras","year":"2018","journal-title":"Curr Drug Discov Technol"},{"issue":"21","key":"pone.0297137.ref035","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension: guidelines from the american heart association and american thoracic society","volume":"132","author":"SH Abman","year":"2015","journal-title":"Circulation"},{"key":"pone.0297137.ref036","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpeds.2015.11.050","article-title":"Recommendations for the use of inhaled nitric oxide therapy in premature newborns with severe pulmonary hypertension","volume":"170","author":"JP Kinsella","year":"2016","journal-title":"J Pediatr"},{"key":"pone.0297137.ref037","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpeds.2019.10.063","article-title":"Just say no to ino in preterms-really?","volume":"218","author":"S Lakshminrusimha","year":"2020","journal-title":"J Pediatr-Us."},{"issue":"2","key":"pone.0297137.ref038","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1542\/peds.2010-3428","article-title":"Inhaled nitric oxide in preterm infants: a systematic review","volume":"127","author":"PK Donohue","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"pone.0297137.ref039","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1542\/peds.2010-3507","article-title":"NIH consensus development conference statement: inhaled nitric-oxide therapy for premature infants","volume":"127","author":"FS Cole","year":"2011","journal-title":"Pediatrics"},{"key":"pone.0297137.ref040","first-page":"CD000509","article-title":"Inhaled nitric oxide for respiratory failure in preterm infants","volume":"1","author":"KJ Barrington","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"pone.0297137.ref041","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/jp.2010.37","article-title":"The changing pattern of inhaled nitric oxide use in the neonatal intensive care unit","volume":"30","author":"RH Clark","year":"2010","journal-title":"J Perinatol"},{"issue":"4","key":"pone.0297137.ref042","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1542\/peds.2014-3290","article-title":"Off-label use of inhaled nitric oxide after release of NIH consensus statement","volume":"135","author":"MA Ellsworth","year":"2015","journal-title":"Pediatrics"},{"issue":"7","key":"pone.0297137.ref043","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(96)00399-3","article-title":"Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension","volume":"28","author":"MM Givertz","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"pone.0297137.ref044","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jfma.2016.10.011","article-title":"Morbidity and mortality of very low birth weight infants in Taiwan\u2014changes in 15 years: a population based study","volume":"115","author":"Y-Y Su","year":"2016","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"pone.0297137.ref045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pedneo.2014.05.002","article-title":"Neonatal outcomes of extremely preterm infants from Taiwan: comparison with Canada, Japan, and the USA.","volume":"56","author":"BH Su","year":"2015","journal-title":"Pediatr Neonatol"},{"issue":"12","key":"pone.0297137.ref046","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1513\/AnnalsATS.201504-218OC","article-title":"Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program.","volume":"12","author":"BB Poindexter","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"pone.0297137.ref047","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000528914","article-title":"European consensus guidelines on the management of respiratory distress syndrome: 2022 update.","volume":"120","author":"DG Sweet","year":"2023","journal-title":"Neonatology."},{"issue":"2","key":"pone.0297137.ref048","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/archdischild-2018-316664","article-title":"Improving incidence trends of severe intraventricular haemorrhages in preterm infants <32 weeks gestation: a cohort study","volume":"105","author":"KT Yeo","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"22","key":"pone.0297137.ref049","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa031154","article-title":"Inhaled nitric oxide in premature infants with the respiratory distress syndrome","volume":"349","author":"MD Schreiber","year":"2003","journal-title":"N Engl J Med"},{"key":"pone.0297137.ref050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/1735-1995.183990","article-title":"Inhaled nitric oxide in preterm infants: an updated meta-analysis","volume":"21","author":"Y Yang","year":"2016","journal-title":"J Res Med Sci"},{"issue":"1","key":"pone.0297137.ref051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/PDR.0b013e3181c1b176","article-title":"Intraventricular hemorrhage in premature infants: mechanism of disease","volume":"67","author":"P. Ballabh","year":"2010","journal-title":"Pediatr Res"},{"issue":"5","key":"pone.0297137.ref052","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.earlhumdev.2005.03.005","article-title":"Autoregulation of cerebral blood flow in newborn babies","volume":"81","author":"G. Greisen","year":"2005","journal-title":"Early Hum Dev"},{"issue":"3","key":"pone.0297137.ref053","doi-asserted-by":"crossref","first-page":"e604","DOI":"10.1542\/peds.2007-1487","article-title":"Impaired autoregulation in preterm infants identified by using spatially resolved spectroscopy","volume":"121","author":"FY Wong","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"pone.0297137.ref054","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/archdischild-2019-316883","article-title":"Burden of hypoxia and intraventricular haemorrhage in extremely preterm infants","volume":"105","author":"IHX Ng","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"16","key":"pone.0297137.ref055","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJMoa2207554","article-title":"Cerebral oximetry monitoring in extremely preterm infants","volume":"388","author":"ML Hansen","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0297137.ref056","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-052456","article-title":"Early-onset sepsis among very preterm infants","volume":"148","author":"DD Flannery","year":"2021","journal-title":"Pediatrics"},{"issue":"6","key":"pone.0297137.ref057","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-058813","article-title":"Late-onset sepsis among very preterm infants","volume":"150","author":"DD Flannery","year":"2022","journal-title":"Pediatrics"},{"issue":"1","key":"pone.0297137.ref058","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge.","volume":"92","author":"G Cavallaro","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"pone.0297137.ref059","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/aos.13384","article-title":"Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches","volume":"96","author":"R Opatrilova","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"pone.0297137.ref060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/jp.2012.84","article-title":"The effect of sildenafil on retinopathy of prematurity in very preterm infants.","volume":"33","author":"AY Fang","year":"2013","journal-title":"J Perinatol"},{"issue":"3","key":"pone.0297137.ref061","doi-asserted-by":"crossref","first-page":"e682","DOI":"10.1542\/peds.2011-1827","article-title":"Prospective analysis of pulmonary hypertension in extremely low birth weight infants","volume":"129","author":"R Bhat","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"pone.0297137.ref062","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12887-017-0910-0","article-title":"Early characteristics of infants with pulmonary hypertension in a referral neonatal intensive care unit","volume":"17","author":"S Vyas-Read","year":"2017","journal-title":"BMC Pediatr"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0297137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T17:31:44Z","timestamp":1715275904000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0297137"}},"subtitle":[],"editor":[{"given":"Fumihiko","family":"Namba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0297137","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}